Virometix AG logo

Virometix AG

Virometix, the privately held Swiss biotechnology company who is developing a new generation of fully synthetic vaccines and immunotherapeutic drugs for the prevention and treatment of infectious diseases and cancer.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.virometix.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Wagisstrasse 14CH-8952
Schlieren
Switzerland
Email
Contact Number
+41 43 433 86 60

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]